Trial intelligence / Profile preview

Urapidil versus nitroglycerin for hypertensive acute heart failure

ChiCTR-TRC-11001781Phase 4Completed

Sponsor
Department of Cardiology, Xuanwu Hospital, Capital Medical University
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Acute Heart Failure (AHF) and hypertension (HTN) comparing Urapidil injection with Nitroglycerin injection (2 arms). Primary endpoints: NT-proBNP and Left ventricular ejection fraction. Started Jan 2012; status: completed.

02

Drugs

urapidilnitroglycerin
03

Conditions

Acute Heart Failure (AHF)hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR-TRC-11001781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call